- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01975805
Chlorhexidine Gluconate Versus Povidone Iodine at Cesarean Delivery: a Randomized Controlled Trial
October 28, 2013 updated by: Ramen Chmait, University of Southern California
To Determine the Difference in Positive Bacterial Cultures in Cesarean Sections With 2% Chlorhexidine- Gluconate, 70% Isopropyl Alcohol (Chloraprep) vs. Povidone-iodine 10% (Betadine) Preoperative Surgical Scrub
Currently there are no published studies comparing the efficacy of Chloraprep and povidone-iodine in decreasing postoperative- wound infection in cesarean sections.
However, there have been studies involving other types of surgery that have compared the efficacy of different types of preoperative cleansing agents in preventing postoperative wound infection.
These studies have shown that controversy exists over which antiseptic skin preparation is the most effective for preventing postoperative surgical wound infections.
The standard of care at Los Angeles County Hospital for preoperative skin antiseptic in cesarean sections is povidone- iodine 10% (betadine), however many other hospitals have made the transition to using Chloraprep.
In an attempt to improve on the current standard of care, we propose a quality improvement prospective randomized study to compare the difference in postoperative wound complications with the use of povidone- iodine and Chloraprep as a preoperative antiseptic in cesarean sections.
We hypothesize that Chloraprep will be better than Betadine at reducing the incidence of positive bacterial cultures following cesarean sections.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Los Angeles, California, United States, 90027
- University of Southern California
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Pregnant women greater than 36 weeks gestation presenting for scheduled repeat cesarean sections and scheduled primary cesarean sections
- Ages 18-45
- Written informed consent obtained
Exclusion Criteria:
- Patients who are taking antimicrobial therapy for any reason
- Patient with a known allergy to one or both of the prepping agents
- Patients currently taking immunosuppressant drugs
- Active acute or chronic infection
- Current history of cancer
- Open wounds, skin ulcers, sores, and severe acne
- History of methicillin-resistant staphylococcus aureus colonization or oxacillin-resistant staphylococcus aureus colonization
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Chlorhexidine Gluconate
Use of Chlorhexidine Gluconate as skin disinfectant for cesarean section.
|
|
Experimental: Povidone Iodine
Use of Povidone Iodine as skin disinfectant for cesarean section.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
To compare the difference in the number of positive bacterial cultures at the site of the incision after preoperative cleansing with povidone iodine and Chloraprep.
Time Frame: 3 min-18 days after skin preparation
|
3 min-18 days after skin preparation
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
To compare the difference in postoperative wound infections measured by the presence of purulent drainage, temp greater than 100.4 F, induration at the site of incision with the use of povidone-iodine and Chloraprep.
Time Frame: Post operative days 0-18
|
Post operative days 0-18
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Cynelle M. Kunkle, MD, University of Southern California
- Principal Investigator: Ramen Chmait, MD, University of Southern California
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2010
Primary Completion (Actual)
March 1, 2012
Study Completion (Actual)
May 1, 2012
Study Registration Dates
First Submitted
October 23, 2013
First Submitted That Met QC Criteria
October 28, 2013
First Posted (Estimate)
November 5, 2013
Study Record Updates
Last Update Posted (Estimate)
November 5, 2013
Last Update Submitted That Met QC Criteria
October 28, 2013
Last Verified
October 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FTP-09-00380
- HS-09-00380 (Other Identifier: USC)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy
-
Far Eastern Memorial HospitalCompletedCornual PregnancyTaiwan
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Ufuk UniversityNot yet recruitingPregnancy Complications | Pregnancy Loss | Pregnancy Preterm
-
Hadassah Medical OrganizationCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompletedProlonged PregnancyFrance
-
University Hospital, ToursCompleted
-
Technische Universität DresdenWithdrawnPregnancy Trimester, Second | Pregnancy Trimester, First | Pregnancy Trimester, ThirdGermany
-
Turku University HospitalUniversity of TurkuCompleted
-
Hopital Antoine BeclereUnknown
-
Universitair Ziekenhuis BrusselMerck Serono International SAUnknownPregnancy | Pregnancy LossBelgium
Clinical Trials on Chlorhexidine Gluconate
-
University of MilanCompleted
-
Universidad de GuanajuatoUnknownVentilator Associated Pneumonia | ChlorhexidineMexico
-
University of Sao PauloCompletedSurgical Site InfectionBrazil
-
Al-Iraqia UniversityCompleted
-
Liaquat National Hospital & Medical CollegeLiaquat College of Medicine and DentostryCompleted
-
Angela BiancoStryker NordicTerminatedCesarean Section | Surgical Site Infection | Nosocomial InfectionUnited States
-
Medline IndustriesCompleted
-
Assistance Publique Hopitaux De MarseilleCompleted
-
Vanderbilt UniversityCompletedSurgical Site InfectionUnited States
-
Johns Hopkins UniversitySage Products, Inc.CompletedNosocomial InfectionsUnited States